The House of Representatives has taken a hardline stance against counterfeit drug manufacturers, proposing the death penalty for those endangering lives through the production of fake medicines. Lawmakers argue that stronger regulations are urgently needed to combat the growing menace, which has led to countless preventable deaths.
The motion, which underscores the severe public health risks posed by counterfeit drugs, has sparked intense debate. Supporters say it will deter offenders, while critics warn of potential legal and enforcement challenges.
Will this bold move become law, or will it face resistance?